nexium
- 网络耐信;埃索美拉唑镁肠溶片
-
Previous studies showed improvement among the children who were administered Nexium .
之前的研究表明使用耐信的儿童症状得到改善。
-
The safety and efficacy of Nexium has not been established in children less than one year of age .
对于小于一岁的患者,耐信的安全性和有效性尚未得到证实。
-
The agency approved Nexium in two forms , a delayed-release capsule and liquid form .
这次批准了耐信的两种剂型,包括一种缓释胶囊和一种口服溶液。
-
Despite that , Nexium was the single most prescribed drug in 2012 , and in many cases it doesn 't even work .
此外,2012年医生开得最多的一种处方药就是耐信,并且多数情况下,它甚至没有一点效用。
-
Nexium is part of a class of drugs known as proton pump inhibitors ( PPIs ) .
耐信是质子泵抑制剂(PPI)奥美拉唑的一种异构体。
-
The FDA approved Nexium on the basis of exploratory research demonstrating the drug 's effectiveness and safety for use with children .
FDA在探索性的研究基础上批准了耐信证明了儿童应用这一药物的有效性和安全性。
-
People suffering from acid reflux rely on anti-acid tablets and drugs such as Prilosec and Nexium .
患上胃酸倒流的人们依靠耐酸药片及奥美拉唑和埃索美拉这样的药物。
-
The most common adverse reactions in children treated with Nexium were headache , diarrhea , abdominal pain , nausea , gas , constipation , dry mouth and sleepiness .
对于儿童患者,在使用耐信治疗中,最常见的不良反应是头痛、腹泻、腹痛、恶心、嗳气、便秘、口干及疲倦。